ATLAS

Key Multicenter Clinical Trials at Shifa International Hospital: 2010- 2014

SANOFI ________ ATLAS__________Asian Treat to Target Lantus Study: A Randomized, Multicenter, Multinational, Open-Label, Parallel-Group, 24-week
Phase IV Study, evaluating the effectiveness and safety of physician versus Patient-LED initiation and titration of Insulin Glargine in type-2 Diabetes Mellitus.